Authors of all types of articles should follow the general instructions given below. These guidelines are in accordance with the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals,” published by the International Committee of Medical Journal Editors (ICMJE) available at www.icmje.org. In addition, JIACM also adheres to Committee on Publication Ethics (COPE) guidelines available at https://publicationethics.org/resources/guidelines.
As stated in the ICMJE recommendations, credit for authorship requires (a) substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data, (b) the drafting of the article or critical revision for important intellectual content, (c) final approval of the version to be published, and (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.
Any change in authorship after submission must be approved in writing by all authors.
In appropriate places in the manuscript, please provide the following items:
- If applicable, a statement that the research protocol was approved by the relevant institutional review boards or ethics committees and that all human participants gave written informed consent
- The identity of those who analyzed the data
- For clinical trials, the registration number in CTRI
Provide an abstract of not more than 250 words. It should consist of four paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the salient results, and what the authors conclude from the results.
Double-space tables (including any footnotes) and provide a title for each.
For Original Articles, there is normally a limit of 5 figures and tables (total) per manuscript.
Photographs of Patients
If photographs of patients are used, either they should not be identifiable or the photographs should be accompanied by written permission to use them.
The ICMJE requires that “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” must be registered before the start of patient enrollment. Trials in which the primary goal is to determine pharmacokinetics are exempt.
Each manuscript will be checked upon submission to determine whether the study needed registration, and if registered, whether the registration is complete and meaningful. Manuscripts will not enter the editorial process until they have passed this screen.
All studies which began enrolling patients after July 1, 2005, must have been registered before patient enrollment. Any trial which was still seeing patients on September 13, 2005, should have been registered before September 13, 2005. If the trial was complete before September 13, 2005, the study should be registered before submission.